Pharma

Consortium will develop a QSP Immuno-oncology Simulator to test combination cancer therapies and different dose regimens and biomarkers in computer-generated, virtual patients
| 3 min read

Consortium will develop a QSP Immuno-oncology Simulator to test combination cancer therapies and different dose regimens and biomarkers in computer-generated, virtual patients